StemRIM (TYO:4599)
285.00
-11.00 (-3.72%)
At close: Feb 6, 2026
StemRIM Employees
StemRIM had 45 employees as of July 31, 2025. The number of employees increased by 1 or 2.27% compared to the previous year.
Employees
45
Change (1Y)
1
Growth (1Y)
2.27%
Revenue / Employee
n/a
Profits / Employee
-42.15M JPY
Market Cap
17.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jul 31, 2025 | 45 | 1 | 2.27% |
| Jul 31, 2024 | 44 | -1 | -2.22% |
| Jul 31, 2023 | 45 | 1 | 2.27% |
| Jul 31, 2022 | 44 | -2 | -4.35% |
| Jul 31, 2021 | 46 | 12 | 35.29% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Japan Tissue Engineering | 204 |
| ReproCELL | 99 |
| RaQualia Pharma | 64 |
| Immuno-Biological Laboratories | 58 |
| AnGes | 55 |
| Stella Pharma | 43 |
| Kidswell Bio | 37 |
| Kubota Pharmaceutical Holdings | 19 |